|
08:30
|
Registration, coffee & networking
|
|
09:15
|
Chairman’s welcome
Koos Oosterhaven, Nizo, The Netherlands
|
|
09:30
|
Working with regulators: real world experiences
Ross Crittenden, Chairman of Global Alliance for Probiotics (GAP)
|
|
10:00
|
Matching probiotic traits to genetic content: a data jungle or a walk in the park?
Dr Michiel Wels, Nijmegen Centre for Molecular Life Sciences and NIZO Food Research, The Netherlands
|
|
10:30
|
Coffee & networking break
|
|
11:05
|
Key global pre-probiotic market snapshots
- Latest developments in established and emerging markets
- BRIC and beyond
Dr Ewa Hudson, Head of Health & Wellness Research, Euromonitor International, UK
|
|
|
PROBIOTECH Stream 1: Science to shelf – commercialising pre-probiotics
|
MICROBIOTA Stream 1: Microbial gut populations, genomics and the reinvention of pre-probiotic science
|
|
11:35
|
Shifting forces in nutrition marketing – 5 global game changers and what they mean for probiotics
1. People: we're getting older
2. Resources: are getting scarce
3. Food: is for health and wellbeing
4. Production: natural and sustainable
5. Science: for a smarter future
Peter Wennstrom, President & Founder, Healthy Marketing Team, UK
|
The Human Microbiome Project: lessons learned and challenges ahead
- An update on the outcomes of human microbiome research
- A detailed case of the microbiome's role in disease
- What will Human Microbiome Project 2 look like?
Dr Dirk Gevers, Broad Institute of MIT & Harvard, USA
|
|
12:00
|
Case study: How a small Swedish probiotic ingredient company won big success through innovative business models
- Taking Lactobacillus plantarum 299v to multiple market segments
- Adapting your business model to market needs
- Many routes to market - launch of a Probi Consumer Healthcare brand
- How to select the right strategic partnerships
Niklas Bjarum, VP Marketing & Sales, Probi, Sweden
|
Is prebiotic modulation of the human gut microflora a health benefit?
- Understanding and transferring prebiotic modulation data outside the lab
- What health benefits are associated with prebiotics?
- Gastrointestinal effects and beyond
Dr Stephan Theis, BENEO Institute, Germany
|
|
12:25
|
Modifying subclinical signs of depression and anxiety with probiotics
Dr Thomas Tompkins, Research Director, Lallemand Health Solutions, France
|
Microbiota, diabetes and liver disease
- Microbial transplantation shows diabetes and liver disease benefits
- Practical applications
Caroline Stokes, Saarland University Medical Center, Germany
|
|
12:50
|
Lunch
|
|
|
PROBIOTECH Stream 2: Science to shelf – commercialising pre-probiotics
|
MICROBIOTA Stream 2: Cosmetic & personal care science and application
|
|
14:00
|
Potential health benefits of postbiotics
Dr Stella C. Knight, Professor of Immunopathology, Imperial College London & Honorary Consultant in Immunopathology, North West London Hospitals Trust
|
Metabolic analysis of the skin microbiome for personal care product development and claims
- How Unilever translates research into NPD in cosmetic products
- Overcoming consumer resistance to microflora on the skin
- Developing deodorants and anti-dandruff products
Dr A. Gordon James, Science Leader – Microbial Metabolism, Unilever, UK
|
|
14:25
|
Probiotics: food or pharma?
- What happens after EFSA?
- Quality monitoring: more than ever?
Dr Bruno Pot, Pasteur Institute, France
|
Oral care considering microbiota knowledge of the human mouth
Professor William Wade, Head of Microbiology Unit, King's College London Dental Institute, UK
|
|
14:50
|
Present status and potential of the probiotic, Symprove
- UK R&D company achieves breakthrough results in large scale IBS study independently run by King's College London
- The science behind 'next generation products'
- Future planned studies
Professor Ingvar Bjarnason, Consultant Physician, King's College Hospital NHS Foundation Trust, UK
Barry Smith, Chairman, Symprove, UK
|
Scientific approach to microbiota and the cosmetic regulations
- Cosmetic and medicinal product regulation
- Antimicrobial peptides in the epidermis
- Sensitive skin and dendritic cells
Corinne Reymermier, R&D Project Supervisor, BASF Beauty Creations, France
|
|
15:15
|
Coffee & networking break
|
|
16:00
|
Application of probiotics in shelf stable foods
Dr Shantanu Das, Innovation and Research Manager, Goodman Fielder; formerly Product Development Manager at Riddet Institute, Massey University, New Zealand
Johan Quintens, Director, Vesale Pharma, Belgium
|
|
16:45
|
Panel discussion
|
|
17:15
|
Chairman’s closing remarks, followed by drinks reception
|
